First-void urine was collected and routinely tested for NG and CT (Aptima Combo 2; Hologic Inc, San Diego, CA). Samples with equivocal results were retested using the Aptima CT single assay (Hologic Inc) and for NG with a quantitative polymerase chain reaction targeting opa genes.17 (link) Urine samples were tested for MG using transcription-mediated amplification (TMA) assays (Aptima, Hologic Inc). From all samples that tested positive for MG in the MG-TMA assay, DNA was extracted with isopropanol precipitation and subsequently tested for macrolide resistance using the MG-MRAM quantitative polymerase chain reaction to detect wild-type (MG-WT) or any mutations (MRAM) in the 23S rRNA gene at nucleotide positions 2058 and 2059 (Escherichia coli numbering).18 (link)Mycoplasma genitalium and MRAM testing were done for study purposes only, and results were disclosed neither to the men nor to the healthcare professionals. A subset of samples was tested for Trichomonas vaginalis (TV) using TMA assays (Aptima, Hologic Inc).